わかもと製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証STD | 医薬品 | 4512/E00928 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2018/10/05 | 日証協 | 127,400株 | -1.09% | 25,300株 | -16.78% | 125,044株 | +20.79% | 9,111株 | -27.11% |
| 2018/09/28 | 日証協 | 128,800株 | +6.1% | 30,400株 | +128.57% | 103,518株 | -17.73% | 12,500株 | +26.26% |
| 2018/09/21 | 日証協 | 121,400株 | +11.27% | 13,300株 | +17.55% | 125,833株 | -0.17% | 9,900株 | +3.12% |
| 2018/09/14 | 日証協 | 109,100株 | +2.63% | 11,314株 | +49.77% | 126,044株 | +0.24% | 9,600株 | +17.07% |
| 2018/09/07 | 日証協 | 106,300株 | -1.94% | 7,554株 | +220.9% | 125,744株 | +1.13% | 8,200株 | +290.48% |
| 2018/08/31 | 日証協 | 108,400株 | -1.63% | 2,354株 | -55.16% | 124,344株 | -0.24% | 2,100株 | -60.38% |
| 2018/08/24 | 日証協 | 110,200株 | -2.22% | 5,250株 | +9.38% | 124,644株 | -7.43% | 5,300株 | -69.36% |
| 2018/08/17 | 日証協 | 112,700株 | -9.11% | 4,800株 | -85.05% | 134,644株 | +4.91% | 17,300株 | +101.16% |
| 2018/08/10 | 日証協 | 124,000株 | -0.32% | 32,100株 | -8.84% | 128,344株 | -9.52% | 8,600株 | -15.69% |
| 2018/08/03 | 日証協 | 124,400株 | -6.61% | 35,212株 | +85.25% | 141,844株 | 0% | 10,200株 | +83.78% |
| 2018/07/27 | 日証協 | 133,200株 | +0.91% | 19,008株 | -51.94% | 141,844株 | -0.63% | 5,550株 | +208.33% |
| 2018/07/20 | 日証協 | 132,000株 | 0% | 39,550株 | 0% | 142,744株 | 0% | 1,800株 | 0% |
| 2018/07/13 | 日証協 | 139,500株 | -1.76% | 49,700株 | -69.19% | 147,944株 | +7.95% | 23,700株 | +238.57% |
| 2018/07/06 | 日証協 | 142,000株 | -6.39% | 161,300株 | +160.79% | 137,044株 | +5.38% | 7,000株 | -63.45% |
| 2018/06/29 | 日証協 | 151,700株 | +8.98% | 61,850株 | +138.34% | 130,044株 | +5.35% | 19,150株 | -7.93% |
| 2018/06/22 | 日証協 | 139,200株 | +3.88% | 25,950株 | +175.95% | 123,444株 | -4.41% | 20,800株 | +347.31% |
| 2018/06/15 | 日証協 | 134,000株 | +3.4% | 9,404株 | +38.27% | 129,144株 | +6.6% | 4,650株 | -70.57% |
| 2018/06/08 | 日証協 | 129,600株 | -3.57% | 6,801株 | -53.57% | 121,145株 | -1.3% | 15,801株 | +51.93% |
| 2018/06/01 | 日証協 | 134,400株 | +5% | 14,647株 | -67.2% | 122,744株 | +0.08% | 10,400株 | -10.34% |
※株式分割は考慮していませんのでご注意ください。
Page Top